Showing 1 posts of 1 posts found.
The chair of NHS England’s cancer drugs fund has said there is likely to be more reviews of affordable treatments …
EnteroBiotix appoints former GSK Chief Medical Officer to board
Stryker invests US$400m in CMR Surgical and secures option to acquire business
AI: an early warning system for patient safety
Tezspire improves symptoms and tissue inflammation in phase 3 EoE trial
Highlighting the value of lab research for healthcare innovation